Skip to content

FES Rowing for Skeletal Health After SCI

Using Musculoskeletal Models to Assess FES Rowing for Skeletal Health After SCI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02008149
Acronym
FES-R
Enrollment
9
Registered
2013-12-11
Start date
2014-11-01
Completion date
2018-12-04
Last updated
2019-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

Osteoporosis

Brief summary

Following a complete spinal cord injury (SCI), individuals experience progressive bone loss, especially in the legs, with up to 70% of persons with SCI sustaining a fracture at some point during their lifetime. Fractures following SCI are costly to treat and more than half of patients experience a medical complication, requiring extended hospitalization, resulting in a substantial impact on their quality of life. To reduce the incidence of fractures, more effective rehabilitation strategies to prevent bone loss are needed. The goal of this research is to determine if bone health can be preserved using an indoor rowing exercise program in which the leg muscles are electrically stimulated using several, small surface electrode pads that are placed on the skin on the front and back thigh muscles. An encouraging case study has recently shown remarkable bone preservation in one individual with SCI who participated in an electrical stimulation rowing program, however, whether other individuals with SCI can achieve the same benefit is currently unknown.

Detailed description

In this study the investigators expect to enroll a total of 10 participants with SCI. Five participants will be assigned to a Standard-of-Care (control) group and five participants will be assigned to an FES-rowing intervention group. Group assignment will be partly based on the preference of each potential participant and their willingness to make the necessary time commitment required for participation in a given group, with the added goal, to the extent possible, of matching the two groups for age, gender and time since injury. Only those individuals who have a strong desire to participate in a regular exercise program and who express a willingness to travel to VA Palo Alto the necessary number of times per week to perform FES-rowing will be potential candidates for inclusion in the rowing group. Bone density measurements for both the Standard-of-Care group and the FES-rowing group will be performed using Dual energy X-ray Absorptiometry (DXA) and peripheral Quantitative Computed Tomography (pQCT). The Standard-of-Care group will undergo no other research procedures. The muscle conditioning program is accomplished through electrical stimulation of the quadriceps and hamstring muscles using a 4-channel electrical stimulator that applies stimulation using surface electrodes adhered using gel to the skin overlying the quadriceps and hamstrings muscles. The muscle strengthening initially takes place three times per week, sixty minutes per session, progressing up to five sessions per week, for approximately 8 weeks. The muscle strengthening program ensures that subjects have sufficient muscle strength and endurance before they embark on the rowing program. Following the 8-week muscle strengthening program, subjects will begin FES-rowing, with three sessions per week, thirty minutes per session for the following 28 weeks. In the FES-rowing group, the investigators will measure isometric knee extension strength at the start of week 0, and at the end of weeks 12, 24 and 36. For the rowing group, the investigators will capture 3D kinetics and kinematics in the motion capture laboratory during FES-rowing at the end of weeks 12, 24 and 36. Kinematics during rowing will be collected from fifty passive retro-reflective markers that will be placed on each participant to capture the position and orientation of the 12 interconnected body segments used to represent each subject.

Interventions

OTHERRowing exercise

Individuals with SCI will use the rowing exerciser to see if there is a benefit to skeletal health in the lower limbs.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Group assignment will be based on the preference of potential subjects. Subjects can either participate in the FES-rowing group or they can participate in the standard-of-care group. The standard-of-care group will not perform FES-rowing; they will only receive periodic bone density measurements over a 36-week period, with a total time commitment of approximately 10 hours. Subjects in the FES-rowing group will participate in rowing sessions requiring a 2 to 3 hour time commitment per week for the duration of the participation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects in the rowing groups: * male and female SCI outpatients or inpatients * have a C7 to T12, ASIA-A or ASIA-B, spinal cord injury * be at least 18 years old * have their physician's clearance to exercise * between 3 and 24 months post spinal cord injury\* * minimum passive hip flexion range of motion (ROM) from 20 to 100 deg * minimum passive knee flexion ROM from 20 to 100 deg * minimum passive ankle ROM from +10 deg (dorsi-flexion) to -15 deg (plantar-flexion) * currently use a manual wheelchair * be able to perform independent and safe transfers to and from their wheelchair \*There is no time post injury restriction for subjects in the experience rower group Subjects in the control group: * male and female SCI outpatients or inpatients * have a C5 to T12, ASIA-A or ASIA-B, spinal cord injury * be at least 18 years old * between 3 and 24 months post spinal cord injury * be able to perform safe transfers to and from their wheelchair, either independently or with assistance

Exclusion criteria

* pregnant women * women of childbearing potential not practicing a reliable method of contraception * women who are post-menopausal * have mechanical instability of the spine * resting blood pressure higher than 140/90 * a grade 1 or greater, sacral, gluteal or ischial pressure ulcer * history of low trauma, lower limb fracture since SCI * renal disease * current osteomyelitis * current thrombosis/hemorrhage * cancer * other neurological disease (i.e. stroke, peripheral neuropathy, myopathy) * any implanted electronic device * active treatment for epilepsy * regular use of tobacco * known coronary artery disease * family history of sudden cardiac death * current use of cardioactive medications, e.g., for treatment of congestive heart failure or arrhythmia * current use of medications that can affect bone density and fracture risk including: * bisphosphonates * parathyroid hormone (PTH) and PTH analogs * androgenic steroids

Design outcomes

Primary

MeasureTime frameDescription
Bone Mineral Density0, 16, 29 and 43 weeksBone mineral density at the distal femur at 0, 16, 29 and 43 weeks measured using peripheral quantitative computed tomography scanning.

Countries

United States

Participant flow

Participants by arm

ArmCount
FES-Rowers
Individuals with complete SCI participating in a 90-session FES-rowing program.
7
Standard-of-Care Controls
Individuals with complete SCI undergoing bone density scanning at four time points over 9 months.
1
Experienced FES-Rower
An individual with more than 10 years of FES-Rowing experience.
1
Total9

Baseline characteristics

CharacteristicFES-RowersTotalExperienced FES-RowerStandard-of-Care Controls
Age, Continuous33 Years35 Years59 Years24 Years
Baseline Bone Mineral Density216.1 g/cm^3221.3 g/cm^3251.2 g/cm^3227.3 g/cm^3
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants3 Participants0 Participants0 Participants
Race (NIH/OMB)
White
4 Participants6 Participants1 Participants1 Participants
Region of Enrollment
United Kingdom
0 Participants1 Participants1 Participants0 Participants
Region of Enrollment
United States
7 Participants8 Participants0 Participants1 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
7 Participants9 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 70 / 10 / 1
other
Total, other adverse events
1 / 70 / 10 / 1
serious
Total, serious adverse events
0 / 70 / 10 / 1

Outcome results

Primary

Bone Mineral Density

Bone mineral density at the distal femur at 0, 16, 29 and 43 weeks measured using peripheral quantitative computed tomography scanning.

Time frame: 0, 16, 29 and 43 weeks

Population: The only participant in the Stanford-of-Care Control group self-withdrew after 12 weeks of participation, after having a baseline measurement and one other bone density measurement. The participant in the Experienced FES-Rower group was only measured at baseline.

ArmMeasureGroupValue (MEAN)
FES-RowersBone Mineral DensityBone Mineral Density at 16 wks184.0 g/cm^3
FES-RowersBone Mineral DensityBone Mineral Density at 29 wks174.9 g/cm^3
FES-RowersBone Mineral DensityBone Mineral Density at 43 wks188.5 g/cm^3

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026